Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 3 479 7272
Email
bruce.russell@otago.ac.nz
Position
Deputy Dean, School of Pharmacy
Qualifications
BPharm(Hons) PhD
Research summary
Biomarkers that enable the prediction of a response to treatment for severe mental health disorders
Teaching
I teach clinical pharmacy to third and fourth year students.
Memberships
  • Member of the Schizophrenia International Research Society (SIRS)
  • Member of the College of Problems on Drug Dependence, USA
  • Member of the Pharmaceutical Society of New Zealand
Clinical
The majority of my research is with patients so I regularly engage with service user groups and enjoy talking to carers and clinical staff whenever possible.

Research

My research focuses on investigating the psychopharmacology and underlying pathophysiology of the severe mental illnesses such as schizophrenia with an emphasis on treatment-resistance. I aim to discover biomarkers that will enable the prediction of an individual's response to drug treatment. I also have an active interest in the psychopharmacology of both new and 'old' recreationally used drugs and the mechanisms underlying drug addiction.

Professor Bruce Russell on Google Scholar

Publications

Merritt, K., McCutcheon, R. A., Aleman, A., Ashley, S., Beck, K., Block, W., … Russell, B. R., … the 1H-MRS in Schizophrenia Investigators. (2023). Variability and magnitude of brain glutamate levels in schizophrenia: A meta and mega-analysis. Molecular Psychiatry. Advance online publication. doi: 10.1038/s41380-023-01991-7

Harrison, O., Russell, B. R., & Pattinson, K. T. S. (2022). Perceptual and ventilatory responses to hypercapnia in athletes and sedentary individuals. Frontiers in Physiology, 13, 820307. doi: 10.3389/fphys.2022.820307

Maharjan, A., Peng, M., Russell, B., & Cakmak, Y. O. (2022). Investigation of the optimal parameters of median nerve stimulation using a variety of stimulation methods and its effects on heart rate variability: A systematic review. Neuromodulation, 25, 1268-1279. doi: 10.1016/j.neurom.2021.10.005

Shadli, S. M., Ando, L. C., McIntosh, J., Lodhia, V., Russell, B. R., Kirk, I. J., Glue, P., & McNaughton, N. (2021). Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker. Scientific Reports, 11, 19746. doi: 10.1038/s41598-021-99374-x

Merritt, K., McGuire, P. K., Egerton, A., and the 1H-MRS in Schizophrenia Investigators, including Russell, B. R. (2021). Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: A mega-analysis of individual participant-level data. JAMA Psychiatry, 78(6), 667-681. doi: 10.1001/jamapsychiatry.2021.0380

McNabb, C. B., Smith, E. R., & Russell, B. R. (2019). Management of mental health disorders and the pharmacist's role: Schizophrenia. In Z. U.-D. Babar (Ed.), Encyclopedia of pharmacy practice and clinical pharmacy (Vol. 3: Part A). (1st ed.) (pp. 686-698). Amsterdam, The Netherlands: Elsevier. doi: 10.1016/B978-0-12-812735-3.00550-1

Chapter in Book - Research

Dalley, J. W., & Russell, B. (2014). Molecular imaging studies in stimulant addiction: A cross-species perspective. In R. A. J. O. Dierckx, A. Otte, E. F. J. de Vries, A. van Waarde & J. A. den Boer (Eds.), PET and SPECT in psychiatry. (pp. 515-534). Berlin, Germany: Springer. doi: 10.1007/978-3-642-40384-2_22

Chapter in Book - Research

Lin, J. C., & Russell, B. R. (2012). Stimulants: Neuroimaging and treatments. In J. J. Canales (Ed.), Emerging targets for drug addiction treatment. (pp. 17-62). Nova Science.

Chapter in Book - Research

Merritt, K., McCutcheon, R. A., Aleman, A., Ashley, S., Beck, K., Block, W., … Russell, B. R., … the 1H-MRS in Schizophrenia Investigators. (2023). Variability and magnitude of brain glutamate levels in schizophrenia: A meta and mega-analysis. Molecular Psychiatry. Advance online publication. doi: 10.1038/s41380-023-01991-7

Journal - Research Article

Harrison, O., Russell, B. R., & Pattinson, K. T. S. (2022). Perceptual and ventilatory responses to hypercapnia in athletes and sedentary individuals. Frontiers in Physiology, 13, 820307. doi: 10.3389/fphys.2022.820307

Journal - Research Article

Maharjan, A., Peng, M., Russell, B., & Cakmak, Y. O. (2022). Investigation of the optimal parameters of median nerve stimulation using a variety of stimulation methods and its effects on heart rate variability: A systematic review. Neuromodulation, 25, 1268-1279. doi: 10.1016/j.neurom.2021.10.005

Journal - Research Article

Merritt, K., McGuire, P. K., Egerton, A., and the 1H-MRS in Schizophrenia Investigators, including Russell, B. R. (2021). Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: A mega-analysis of individual participant-level data. JAMA Psychiatry, 78(6), 667-681. doi: 10.1001/jamapsychiatry.2021.0380

Journal - Research Article

Ram, S., Russell, B. R., Stewart, K., Kirkpatrick, C., Henning, M., Scahill, S., & Hussainy, S. (2021). Psychiatrists’ attitudes towards and willingness to prescribe cognitive enhancers in academic settings. Drugs: Education, Prevention, & Policy, 28(1), 59-66. doi: 10.1080/09687637.2020.1735303

Journal - Research Article

Searchfield, G. D., Spiegel, D. P., Poppe, T. N. E. R., Durai, M., Jensen, M., Kobayashi, K., … Russell, B. R., … Wise, K. J. (2021). A proof-of-concept study comparing tinnitus and neural connectivity changes following multisensory perceptual training with and without a low-dose of fluoxetine. International Journal of Neuroscience, 131(5), 433-444. doi: 10.1080/00207454.2020.1746310

Journal - Research Article

Shadli, S. M., Ando, L. C., McIntosh, J., Lodhia, V., Russell, B. R., Kirk, I. J., Glue, P., & McNaughton, N. (2021). Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker. Scientific Reports, 11, 19746. doi: 10.1038/s41598-021-99374-x

Journal - Research Article

McNabb, C. B., McIlwain, M. E., Anderson, V. M., Kydd, R. R., Sundram, F., & Russell, B. R. (2020). Aberrant white matter microstructure in treatment-resistant schizophrenia. Psychiatry Research: Neuroimaging, 305, 111198. doi: 10.1016/j.pscychresns.2020.111198

Journal - Research Article

Ram, S., Russell, B., Kirkpatrick, C., Stewart, K., Scahill, S., Henning, M., … Hussainy, S. (2020). Professionals' attitudes towards the use of cognitive enhancers in academic settings. PLoS ONE, 15(11), e0241968. doi: 10.1371/journal.pone.0241968

Journal - Research Article

Sabrini, S., Russell, B., Wang, G. Y., Lin, J., Kirk, I., & Curley, L. (2020). Methamphetamine induces neuronal death: Evidence from rodent studies. NeuroToxicology, 77, 20-28. doi: 10.1016/j.neuro.2019.12.006

Journal - Research Article

Searchfield, G. D., Poppe, T. N. E. R., Durai, M., Jensen, M., Kennedy, M. A., Maggo, S., Miller, A. L., … Russell, B. R., … Wise, K. (2020). A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity. International Journal of Neuroscience, 130(7), 671-682. doi: 10.1080/00207454.2019.1702544

Journal - Research Article

Lagas, A. K., Black, J. M., Russell, B. R., Kydd, R. R., & Thompson, B. (2019). The effect of combined patching and citalopram on visual acuity in adults with amblyopia: A randomized, crossover, placebo-controlled trial. Neural Plasticity, 2019, 5857243. doi: 10.1155/2019/5857243

Journal - Research Article

Ram, S., Hussainy, S., Henning, M., Jensen, M., Stewart, K., & Russell, B. (2019). Cognitive enhancers (CE) and learning strategies. Journal of Cognitive Enhancement, 3(1), 124-130. doi: 10.1007/s41465-018-0089-9

Journal - Research Article

Spriggs, M. J., Thompson, C. S., Moreau, D., McNair, N. A., Wu, C. C., Lamb, Y. N., … Russell, B. R., … Kirk, I. J. (2019). Human sensory LTP predicts memory performance and is modulated by the BDNF Val66Met polymorphism. Frontiers in Human Neuroscience, 13, 22. doi: 10.3389/fnhum.2019.00022

Journal - Research Article

McNabb, C. B., Kydd, R., Sundram, F., Soosay, I., & Russell, B. R. (2018). Differences in white matter connectivity between treatment-resistant and treatment-responsive subtypes of schizophrenia. Psychiatry Research: Neuroimaging, 283, 47-54. doi: 10.1016/j.pscychresns.2018.11.002

Journal - Research Article

McNabb, C. B., Sundram, F., Soosay, I., Kydd, R. R., & Russell, B. R. (2018). Increased sensorimotor network connectivity associated with clozapine eligibility in people with schizophrenia. Psychiatry Research: Neuroimaging, 275, 36-42. doi: 10.1016/j.pscychresns.2018.02.008

Journal - Research Article

McNabb, C. B., Tait, R. J., McIlwain, M. E., Anderson, V. M., Suckling, J., Kydd, R. R., & Russell, B. R. (2018). Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia. Schizophrenia Research, 195, 160-167. doi: 10.1016/j.schres.2017.10.015

Journal - Research Article

Sengupta, N., McNabb, C. B., Kasabov, N., & Russell, B. R. (2018). Integrating space, time, and orientation in spiking neural networks: A case study on multimodal brain data modeling. IEEE Transactions on Neural Networks & Learning Systems, 29(11), 5249-5263. doi: 10.1109/TNNLS.2018.2796023

Journal - Research Article

McIntosh, H. D., Russell, B. R., Cochran, J. R., & Sollers, III, J. J. (2017). The heart of the pressor effect: Acute caffeine ingestion and resting heart rate variability. Journal of Caffeine Research, 7(1), 23-30. doi: 10.1089/jcr.2016.0003

Journal - Research Article

Ram, S., Hussainy, S., Henning, M., Stewart, K., Jensen, M., & Russell, B. (2017). Attitudes toward cognitive enhancer use among New Zealand tertiary students. Substance Use & Misuse, 52(11), 1387-1392. doi: 10.1080/10826084.2017.1281313

Journal - Research Article

Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Using fMRI to compare the effects of benzylpiperazine with dexamphetamine: Their differences during the Stroop paradigm. Journal of Integrative Neuroscience, 15, 109. doi: 10.1142/S0219635216500084

Journal - Research Article

Doborjeh, M. G., Wang, G. Y., Kasabov, N. K., Kydd, R., & Russell, B. (2016). A spiking neural network methodology and system for learning and comparative analysis of EEG data from healthy versus addiction treated versus addiction not treated subjects. IEEE Transactions on Biomedical Engineering, 63(9), 1830-1841. doi: 10.1109/TBME.2015.2503400

Journal - Research Article

Lagas, A. K., Black, J. M., Byblow, W. D., Fleming, M. K., Goodman, L. K., Kydd, R. R., Russell, B. R., … Thompson, B. (2016). Fluoxetine does not enhance visual perceptual learning and triazolam specifically impairs learning transfer. Frontiers in Human Neuroscience, 10, 532. doi: 10.3389/fnhum.2016.00532

Journal - Research Article

Lee, H., Wang, G. Y., Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography. Psychopharmacology, 233(15), 2869-2877. doi: 10.1007/s00213-016-4335-5

Journal - Research Article

Lee, H., Wang, G. Y., Curley, L. E., Sollers, J. J., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: A single-dose study. Psychopharmacology, 233(5), 863-871. doi: 10.1007/s00213-015-4165-x

Journal - Research Article

McGregor, A. L., Dysart, J., Tingle, M. D., Russell, B. R., Kydd, R. R., & Finucane, G. (2016). Varenicline improves motor and cognitive symptoms in early Huntington’s disease. Neuropsychiatric Disease & Treatment, 12, 2381-2386. doi: 10.2147/NDT.S111083

Journal - Research Article

Ram, S., Hussainy, S., Henning, M., Jensen, M., & Russell, B. (2016). Prevalence of cognitive enhancer use among New Zealand tertiary students. Drug & Alcohol Review, 35(3), 345-351. doi: 10.1111/dar.12294

Journal - Research Article

Wang, G. Y., Kydd, R. R., & Russell, B. R. (2016). Quantitative EEG and low-resolution electromagnetic tomography (LORETA) imaging of patients undergoing methadone treatment for opiate addiction. Clinical EEG & Neuroscience, 47(3), 180-187. doi: 10.1177/1550059415586705

Journal - Research Article

Anderson, V. M., Goldstein, M. E., Kydd, R. R., & Russell, B. R. (2015). Extensive gray matter volume reduction in treatment-resistant schizophrenia. International Journal of Neuropsychopharmacology, 18(7), pyv016. doi: 10.1093/ijnp/pyv016

Journal - Research Article

Anderson, V. M., McIlwain, M. E., Kydd, R. R., & Russell, B. R. (2015). Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders? Psychiatry Research, 230(3), 811-818. doi: 10.1016/j.psychres.2015.10.036

Journal - Research Article

Curley, L. E., Kydd, R. R., Robertson, M. C., Pillai, A., McNair, N., Lee, H., … Russell, B. R. (2015). Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task: A pilot study. Psychopharmacology, 232(16), 2969-2980. doi: 10.1007/s00213-015-3933-y

Journal - Research Article

Goldstein, M. E., Anderson, V. M., Pillai, A., Kydd, R. R., & Russell, B. R. (2015). Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia. International Journal of Neuropsychopharmacology, 18(6), pyu117. doi: 10.1093/ijnp/pyu117

Journal - Research Article

Lin, J. C., Jan, R. K., Kydd, R. R., & Russell, B. R. (2015). Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers. Drug & Alcohol Dependence, 149, 122-127. doi: 10.1016/j.drugalcdep.2015.01.026

Journal - Research Article

Turner, C. E., Russell, B. R., & Gant, N. (2015). Comparative quantification of dietary supplemented neural creatine concentrations with 1H-MRS peak fitting and basis spectrum methods. Magnetic Resonance Imaging, 33(9), 1163-1167. doi: 10.1016/j.mri.2015.06.018

Journal - Research Article

Wang, G. Y., Kydd, R., & Russell, B. R. (2015). Auditory event-related potentials in methadone substituted opiate users. Journal of Psychopharmacology, 29(9), 983-995. doi: 10.1177/0269881115587929

Journal - Research Article

Wang, G. Y., Kydd, R., & Russell, B. R. (2015). Resting EEG and ERPs findings in methadone-substituted opiate users: A review. Acta Neurologica Belgica, 115(4), 539-546. doi: 10.1007/s13760-015-0476-2

Journal - Research Article

Wang, G. Y., Kydd, R., Wouldes, T. A., Jensen, M., & Russell, B. R. (2015). Changes in resting EEG following methadone treatment in opiate addicts. Clinical Neurophysiology, 126(5), 943-950. doi: 10.1016/j.clinph.2014.08.021

Journal - Research Article

Jan, R. K., Lin, J. C., McLaren, D. G., Kirk, I. J., Kydd, R. R., & Russell, B. R. (2014). The effects of methylphenidate on cognitive control in active methamphetamine dependence using functional magnetic resonance imaging. Frontiers in Psychiatry, 5, 20. doi: 10.3389/fpsyt.2014.00020

Journal - Research Article

Wang, G. Y., Wouldes, T. A., Kydd, R., Jensen, M., & Russell, B. R. (2014). Neuropsychological performance of methadone-maintained opiate users. Journal of Psychopharmacology, 28(8), 789-799. doi: 10.1177/0269881114538541

Journal - Research Article

Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2013). Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI). Psychopharmacology, 229(4), 673-685. doi: 10.1007/s00213-013-3128-3

Journal - Research Article

Miles, S. W., Sheridan, J., Russell, B., Kydd, R., Wheeler, A., Walters, C., … Tiihonen, J. (2013). Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: A randomized, double-blind, placebo-controlled trial. Addiction, 108(7), 1279-1286. doi: 10.1111/add.12109

Journal - Research Article

Sun, Y., Evans, J., Russell, B., Kydd, R., & Connor, B. (2013). A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress. Neuropharmacology, 72, 20-28. doi: 10.1016/j.neuropharm.2013.04.021

Journal - Research Article

Wang, G. Y., Wouldes, T. A., & Russell, B. R. (2013). Methadone maintenance treatment and cognitive function: A systematic review. Current Drug Abuse Reviews, 6(3), 220-230. doi: 10.2174/18744737112059990020

Journal - Research Article

Young, S. A., Thrimawithana, T. R., Antia, U., Fredatovich, J. D., Na, Y., Neale, P. T., … Russell, B. (2013). Pharmaceutical quality of "party pills" raises additional safety concerns in the use of illicit recreational drugs. New Zealand Medical Journal, 126(1376). Retrieved from http://www.nzma.org.nz/journal

Journal - Research Article

Jan, R. K., Kydd, R. R., & Russell, B. R. (2012). Functional and structural brain changes associated with methamphetamine abuse. Brain Sciences, 2(4), 434-482. doi: 10.3390/brainsci2040434

Journal - Research Article

Jan, R. K., Lin, J. C., Miles, S. W., Kydd, R. R., & Russell, B. R. (2012). Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance. Brain Sciences, 2(4), 553-572. doi: 10.3390/brainsci2040553

Journal - Research Article

McNabb, C. B., Russell, B. R., Caprioli, D., Nutt, D. J., Gibbons, S., & Dalley, J. W. (2012). Single chemical entity legal highs: Assessing the risk for long term harm. Current Drug Abuse Reviews, 5(4), 304-319. doi: 10.2174/1874473711205040005

Journal - Research Article

Ram, S., Russell, B., Gubb, M., Taylor, R., Butler, C., Khan, I., & Shelling, A. (2012). General practitioner attitudes to direct-to-consumer genetic testing in New Zealand. New Zealand Medical Journal, 125(1364), 14-26. Retrieved from http://www.nzma.org.nz/journal

Journal - Research Article

Lee, H., Kydd, R. R., Lim, V. K., Kirk, I. J., & Russell, B. R. (2011). Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication. Psychopharmacology, 213(4), 707-714. doi: 10.1007/s00213-010-2025-2

Journal - Research Article

Lin, J. C., Jan, R. K., Kydd, R. R., & Russell, B. R. (2011). Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination. Drug Testing & Analysis, 3(9), 582-585. doi: 10.1002/dta.285

Journal - Research Article

Lin, J. C., Jan, R. K., Lee, H., Jensen, M.-A., Kydd, R. R., & Russell, B. R. (2011). Determining the subjective and physiological effects of BZP combined with TFMPP in human males. Psychopharmacology, 214(3), 761-768. doi: 10.1007/s00213-010-2081-7

Journal - Research Article

McIlwain, M. E., Harrison, J., Wheeler, A. J., & Russell, B. R. (2011). Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatric Disease & Treatment, 7(1), 135-149. doi: 10.2147/NDT.S12769

Journal - Research Article

Thornley, S., Russell, B., & Kydd, R. (2011). Carbohydrate reward and psychosis: An explanation for neuroleptic induced weight gain and path to improved mental health? Current Neuropharmacology, 9(2), 370-375. doi: 10.2174/157015911795596513

Journal - Research Article

Anita, U., Tingle, M. D., & Russell, B. R. (2010). Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans. Journal of Forensic Sciences, 55(5), 1311-1318. doi: 10.1111/j.1556-4029.2010.01457.x

Journal - Research Article

Jan, R. K., Lin, J. C., Lee, H., Sheridan, J. L., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2010). Determining the subjective effects of TFMPP in human males. Psychopharmacology, 211(3), 347-353. doi: 10.1007/s00213-010-1911-y

Journal - Research Article

Anita, U., Tingle, M. D., & Russell, B. R. (2009). 'Party pill' drugs: BZP and TFMPP. New Zealand Medical Journal, 123, 1307, 55-68.

Journal - Research Article

Antia, U., Lee, H. S., Kydd, R. R., Tingle, M. D., & Russell, B. R. (2009). Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Science International, 186(1-3), 63-67. doi: 10.1016/j.forsciint.2009.01.015

Journal - Research Article

Antia, U., Tingle, M. D., & Russell, B. R. (2009). In vivo interactions between BZP and TFMPP (party pill drugs). New Zealand Medical Journal, 122(1303), 29-38. Retrieved from https://www.nzma.org.nz/journal

Journal - Research Article

Antia, U., Tingle, M. D., & Russell, B. R. (2009). Metabolic interactions with piperazine-based 'party pill' drugs. Journal of Pharmacy & Pharmacology, 61(7), 877-882. doi: 10.1211/jpp/61.07.0006

Journal - Research Article

Lin, J. C., Bangs, N., Lee, H., Kydd, R. R., & Russell, B. R. (2009). Determining the subjective and physiological effects of BZP on human females. Psychopharmacology, 207(3), 439-446. doi: 10.1007/s00213-009-1669-2

Journal - Research Article

Murphy, M., Antia, U., Chang, H.-Y., Han, J. Y., Ibrahim, A., Tingle, M., & Russell, B. (2009). Party pills and drug-drug interactions. New Zealand Medical Journal, 122(1293), 16-25. Retrieved from https://www.nzma.org.nz/journal

Journal - Research Article

Sheridan, J., Butler, R., Wilkins, C., & Russell, B. (2007). Legal piperazine-containing party pills: A new trend in substance misuse. Drug & Alcohol Review, 26(3), 335-343. doi: 10.1080/09595230701255791

Journal - Research Article

Russell, B. R., & Laverty, R. (2001). The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity and neurotoxicity. Pharmacology Biochemistry & Behavior, 68(3), 565-574. doi: 10.1016/S0091-3057(01)00454-3

Journal - Research Article

Russell, B. R., & Laverty, R. (2000). Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021. Annals of the New York Academy of Sciences, 914, 208-214. doi: 10.1111/j.1749-6632.2000.tb05197.x

Journal - Research Article

Zheng, Y., Russell, B., Schmierer, D., & Laverty, R. (1997). The effects of aminorex and related compounds on brain monoamines and metabolites in CBA mice. Journal of Pharmacy & Pharmacology, 49(1), 89-96. doi: 10.1111/j.2042-7158.1997.tb06758.x

Journal - Research Article

Russell, B. R., Beresford, R. A., Schmierer, D. M., McNaughton, N., & Clark, C. R. (1995). Stimulus properties of some analogues of 4-methylaminorex. Pharmacology Biochemistry & Behavior, 51(2-3), 375-378. doi: 10.1016/0091-3057(94)00407-A

Journal - Research Article

Glue, P., Russell, B., & Medlicott, N. J. (2021). Influence of formulation and route of administration on ketamine's safety and tolerability: Systematic review. European Journal of Clinical Pharmacology, 77, 671-676. doi: 10.1007/s00228-020-03047-z

Journal - Research Other

Wilkins, C., Sheridan, J., Adams, P., Russell, B., & Newcombe, D. (2013). Reply to Sumnall (2013): 'The New Zealand new psychoactive substances regime: A step in the right direction, but questions still remain'. Journal of Psychopharmacology, 27(11), 1078-1079. doi: 10.1177/0269881113503507a

Journal - Research Other

Wilkins, C., Sheridan, J., Adams, P., Russell, B., Ram, S., & Newcombe, D. (2013). The new psychoactive substances regime in New Zealand: A different approach to regulation [Perspective]. Journal of Psychopharmacology, 27(7), 584-589. doi: 10.1177/0269881113491441

Journal - Research Other

Sheridan, J., Atmore, B., & Russell, B. (2012). New Zealand to establish fit for purpose regulation for new psychoactive substances. Addiction, 107(11), 1901-1902. doi: 10.1111/j.1360-0443.2012.03809.x

Journal - Research Other

Hardy, I., Alany, R., Russell, B., & Hardy, G. (2006). Antimicrobial effects of arginine and nitrogen oxides and their potential role in sepsis [Editorial]. Current Opinion in Clinical Nutrition & Metabolic Care, 9(3), 225-232. doi: 10.1097/01.mco.0000222104.23171.58

Journal - Research Other

Back to top